MD1094Z - Method for diagnosis of gastroesophageal reflux disease - Google Patents
Method for diagnosis of gastroesophageal reflux diseaseInfo
- Publication number
- MD1094Z MD1094Z MDS20160048A MDS20160048A MD1094Z MD 1094 Z MD1094 Z MD 1094Z MD S20160048 A MDS20160048 A MD S20160048A MD S20160048 A MDS20160048 A MD S20160048A MD 1094 Z MD1094 Z MD 1094Z
- Authority
- MD
- Moldova
- Prior art keywords
- diagnosis
- gastroesophageal reflux
- reflux disease
- symptoms
- disease
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 208000024891 symptom Diseases 0.000 abstract 3
- 206010008479 Chest Pain Diseases 0.000 abstract 1
- 206010067171 Regurgitation Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, in particular to gastroenterology and may be used for diagnosis of gastroesophageal reflux disease.Summary of the invention consists in that it is carried out the clinical examination, and then is administered 20 mg of (RS)-2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole, per os, and after 24 hours is repeatedly carried out the clinical examination with assessment of symptoms, such as retrosternal pain, regurgitations, namely their duration and expression, the factors that improve and/or deteriorate them, the impact of these symptoms on the quality of life, by assigning points for each symptom. In the case where the total score is up to 53, it is determined the absence of the disease, and when is 53 or more - it is set the diagnosis of gastroesophageal reflux disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20160048A MD1094Z (en) | 2016-03-31 | 2016-03-31 | Method for diagnosis of gastroesophageal reflux disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20160048A MD1094Z (en) | 2016-03-31 | 2016-03-31 | Method for diagnosis of gastroesophageal reflux disease |
Publications (2)
Publication Number | Publication Date |
---|---|
MD1094Y MD1094Y (en) | 2016-11-30 |
MD1094Z true MD1094Z (en) | 2017-06-30 |
Family
ID=57424890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDS20160048A MD1094Z (en) | 2016-03-31 | 2016-03-31 | Method for diagnosis of gastroesophageal reflux disease |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD1094Z (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2725603C1 (en) * | 2020-03-30 | 2020-07-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования Северо-Западный государственный медицинский университет им. И.И. Мечникова Министерства здравоохранения Российской Федерации | Method for non-invasive diagnosis of gastroesophageal reflux disease phenotypes |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1304804A1 (en) * | 1984-09-25 | 1987-04-23 | Минский государственный медицинский институт | Method of diagnosis of gastroesophageal reflux |
SU1364347A1 (en) * | 1985-12-10 | 1988-01-07 | Латвийский Научно-Исследовательский Институт Экспериментальной И Клинической Медицины | Method of diagnosis of gastroesophageal reflux |
SU1380731A1 (en) * | 1986-02-27 | 1988-03-15 | Днепропетровский Научно-Исследовательский Институт Гастроэнтерологии | Method of determining the degree of manifestation of gastroesophageal reflux by means of ph-probing of stomach |
SU1421307A1 (en) * | 1985-05-27 | 1988-09-07 | Минский государственный медицинский институт | Method of diagnosis of gastroesophageal reflux of children |
MD202G2 (en) * | 1993-05-05 | 1996-01-31 | Государственный Университет Молд0 | Method of active gamma-MnO2 preparing |
MD2160G2 (en) * | 2003-01-23 | 2003-11-30 | СКОРПАН Анатолие | Method of diagnosis of the reflux esophagitis gravity degree |
-
2016
- 2016-03-31 MD MDS20160048A patent/MD1094Z/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1304804A1 (en) * | 1984-09-25 | 1987-04-23 | Минский государственный медицинский институт | Method of diagnosis of gastroesophageal reflux |
SU1421307A1 (en) * | 1985-05-27 | 1988-09-07 | Минский государственный медицинский институт | Method of diagnosis of gastroesophageal reflux of children |
SU1364347A1 (en) * | 1985-12-10 | 1988-01-07 | Латвийский Научно-Исследовательский Институт Экспериментальной И Клинической Медицины | Method of diagnosis of gastroesophageal reflux |
SU1380731A1 (en) * | 1986-02-27 | 1988-03-15 | Днепропетровский Научно-Исследовательский Институт Гастроэнтерологии | Method of determining the degree of manifestation of gastroesophageal reflux by means of ph-probing of stomach |
MD202G2 (en) * | 1993-05-05 | 1996-01-31 | Государственный Университет Молд0 | Method of active gamma-MnO2 preparing |
MD2160G2 (en) * | 2003-01-23 | 2003-11-30 | СКОРПАН Анатолие | Method of diagnosis of the reflux esophagitis gravity degree |
Non-Patent Citations (4)
Title |
---|
American gastroenterological association. Medical Position Statement: Guidelines on the Use of Esophageal pH. Gastroenterology, 1996, vol.110, p.1981-1996 * |
Jones R., Junghard O., Dent J. et al. Development of the GERDQ, a tool for diagnosis and management of gastro-esofageal reflux disease in primary care. Aliment. Pharmacol. Ter., 2009, 30, p. 1030-1038 * |
Katz P.O., Gerson L.B., Vela M.F. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am. J. Gastroenterol., 2013, 108, p. 308-328 * |
Position Statement: Guidelines on the Use of Esophageal pH. Gastroenterology, 1996, vol.110, p.1981-1996. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2725603C1 (en) * | 2020-03-30 | 2020-07-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования Северо-Западный государственный медицинский университет им. И.И. Мечникова Министерства здравоохранения Российской Федерации | Method for non-invasive diagnosis of gastroesophageal reflux disease phenotypes |
Also Published As
Publication number | Publication date |
---|---|
MD1094Y (en) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017114346A (en) | ANTAGONISTS INTEGRINE ανβ6 | |
CN106659757A8 (en) | The super agonist of interleukin-22, partial agonist and antagonist | |
UA117103C2 (en) | Glucagon analogues | |
MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
MX2018013476A (en) | Compositions for treating acid-base disorders. | |
EA201890891A1 (en) | BIOMARKERS ASSOCIATED WITH INTERLEYKIN-33 DISEASES, AND THEIR APPLICATION | |
EA201790563A1 (en) | APPLICATION OF WOODLIZUMAB FOR THE TREATMENT OF EOSINOPHIL ASTHMA WITH A DEGREE OF DIFFERENCE TO HEAVY | |
TW201613932A (en) | Organic compounds | |
EA201791021A1 (en) | 1- [2- (AMINOMETHYL) BENZYL] -2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO [3,2-d] PYRIMIDIN-4-ONE AS INHIBITORS MYELOPEROXIDASE | |
EA201401353A1 (en) | BIOMARKERS TO DETERMINE AN EFFECTIVE RESPONSE RESPONSE TO THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) | |
MX2018000883A (en) | Crystalline forms of bilastine and preparation methods thereof. | |
WO2011137322A3 (en) | Methods and compositions for treating celiac disease | |
MD1094Y (en) | Method for diagnosis of gastroesophageal reflux disease | |
WO2014169011A3 (en) | Methods for treating immune diseases | |
WO2015120436A3 (en) | Stat3 phosphorylation during graft-versus-host disease | |
WO2018204377A3 (en) | TUMOR VS. MATCHED NORMAL cfRNA | |
Haines et al. | C44 critical illness predictors and outcomes: longer term outcomes following critical care: preliminary results of the Australian experience | |
EA201491870A1 (en) | METHOD OF TREATING HYPERURICEMIA IN PATIENTS WITH GONATHRITIS THROUGH HALOPHENATE OR HALOPHENIC ACID AND ANTI-INFLAMMATORY AGENT | |
Paly et al. | The prevalence of gastroesophageal reflux disease in patients with pathology digestive system, the triggers and effective blocker of Н+/K+-ATPase (according to the survey of outpatients) | |
Brownschidle | Melaena: case report | |
Blanco et al. | C52 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION I: Quality Of Life In Pulmonary Hypertension: Impact Of Proper Medical Treatment | |
Yusupaliieva | The quality of life in patients with chronic obstructive pulmonary disease with comorbid arterial hypertension | |
Elahee et al. | C70 CALL MY NAME: CASE REPORTS IN PULMONARY VASCULAR DISEASE: Rivaroxaban Treatment Failure: A Case Report | |
Hatemi | Pneumonia, respiratory failure and sepsis: case report | |
XIN et al. | Synergistic effect of family hypertension history and hyperuricemia on incidence of hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG9Y | Short term patent issued | ||
KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |